Chi Longevity
Chi Longevity scored 74/100 on Panya's 11-signal vendor rubric. Each signal is scored 0 to 100, the methodology is public, and our affiliate posture is flat-fee · never pay-to-rank. Below is the full per-signal breakdown.
- COA on every lot80
- Cold-chain verified85
- Rx legality (HSA)MOH-compliant95
- Compound identity85
- Dose accuracyProf Maier (NUS)90
- Endotoxin testing75
- Refund posture60
- Channel clarity95
- Support quality80
- Price transparencypremium SGD 5-15k65
- Longitudinal retentionlongevity programme80
HSA-registered; longevity clinics + hybrid telehealth all stocking. No reported gaps.
More reliable than Wegovy at most SG providers.
Demand outstripped supply post-2024; expect 1-3 week stock gaps at retail apoteks. Hybrid telehealth platforms substitute Ozempic when Wegovy runs dry.
The 11-signal rubric is public.
Identity, dose accuracy, COA, cold-chain, Rx legality, compound identity, endotoxin testing, refund posture, channel clarity, support quality, price transparency, longitudinal retention. Each scored 0 to 100. Vendors that fail our floor are silently filtered out · they don't appear in our match flow at all.
If Chi Longevity wants to dispute or update this score, contact partner@panya.health. Score updates are recorded on this page with a public changelog.
Want a match for your situation?
Take the 2-minute quiz. We'll match you against this and the other vendors in your region · based on your dose, urgency, and budget.
We earn a small commission when you buy through recommended vendors. That is how this stays free. Vendors rank by quality signals, not paid placement.